Turning Innovation Into Acquisition: A Biotech Entrepreneur’s Guide

Join us on Friday, August 23 as part of the Case Western Reserve University Entrepreneurship Speaker Series for a roundtable discussion with Timothy Miller, PhD ('08), Co-founder and President at Forge Biologics.

Timothy Miller is Co-Founder, President & CEO of Forge Biologics, Inc., a VC-backed gene therapy development engine focused on accelerating access to potentially live-saving AAV gene therapies. Founding CEO & President of Abeona Therapeutics, a rare disease NASDAQ gene/cell therapy company. A proven biotech leader with experience in driving gene therapy pipeline development, regulatory strategy, investor relations, M&A activities, in-licensing, GMP manufacturing, clinical development and leading stakeholder/shareholder engagement. Dr. Miller has over 20+ years of business development, scientific research, product development and clinical operations expertise, with a focus on transitioning novel gene and cell therapies through pre-clinical - Phase 3 human clinical trials. A public/private biotechnology professional with a Ph.D. in Pharmacology, Bachelor of Science (B.S.), Master of Science (M.S.) focused in Biology/Molecular Biology from John Carroll University. He is an avid patient-centric drug developer and entrepreneur.

To register for this event, please indicate your in-person or virtual attendance. We will also be broadcasting this roundtable to LinkedIn Live on our LinkedIn page.

The Veale Institute for Entrepreneurship hosts discussions from highly-accomplished industry professionals to speak with current students and alumni who are interested in topics within the entrepreneurial ecosystem. Participating guests are encouraged to arrive prepared with questions and topics for discussion.

CWRU Entrepreneurship | Website | View More Events
Co-hosted with: Explore

Contact the organizers